Proprietary CMO Cell Culture Technology Platforms are Disrupting the In-house-outsourced Balance of Cell Banking Services
This market insight on the global cell banking market analyses disruptive technologies and provides details on game-changing companies. Biopharmaceutical companies are increasingly partnering with CMOs and CROs to store their proprietary cell lines and develop new ones. With increased collaborations, CMOs are coming up with niche and specific services for cell line development and cell banking. They are focusing on providing gene to GMP services, thereby expanding their service portfolios.
Mammalian cell culture technology is the highest-growing system across all other cell systems. With the increase in infectious diseases, the development of novel mammalian cell culture systems is expected to evolve. With the growing need for the proper storage of cultured cell banks, CMOs are developing long-term preservation techniques through continuous temperature monitoring. With the emergence of single-use technologies and new developments in cryopreservation technologies and upstream/downstream processes, the cell banking market is expected to experience robust growth, with the major share being captured by contractors as they specialise in new technologies. CMOs are turning towards emerging markets such as Asia-Pacific.
However, issues with delivery, service, IP protection, and regulatory and product quality are curbing growth. The key companies covered in the study include SGS Life Sciences, Charles River Laboratories, Wuxi AppTech, BioReliance Corporation, Eurofins, and Lonza.
Our reports have been used by over 10K customers, including:
The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research. Many of the current biologics in the pipeline are targeting the indications, which are small-molecule...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
276 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Dec 2020
A recent market study published on the Mammalian Transient Protein Expression market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics and Covid-19 crisis impact analysis. After conducting a thorough research on the historical...
Insulin Like Growth Factor I - Pipeline Review, H2 2020
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Insulin-like growth factor 1 (IGF-1) also called somatomedin C is a protein encoded by the IGF1 gene. It stimulates glucose transport in bone-derived...
Report Synopsis Due to the COVID-19 Pandemic, telehealth and tele-detailing (also called remoter detailing or web calls) have set forth that allow a biosimilars companies’ commercialization branch to have a wide range with less few reps. Also, the fluidity of the labor market is another new dynamic allowing for a greater...
“HYQVIA - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chronic inflammatory demyelinating Syndrome in 7 Major Markets. A detailed picture of the HYQVIA in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and...
The Asia Pacific Medical Thawing System Market would witness market growth of 12% CAGR during the forecast period (2020-2026). The region comprises of growing economies, significantly China, India, and Japan. These nations consist of a huge number of patients with a high chronic disease rate. A rise in the number of chronic diseases...
The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period. Increasing use of single-use bioreactors for bioprocessing, rising investmnet in R&D for developemnt of vaccines and therapeutic protiens, and increasing government funding for cell and gene therapy. •...
The Europe Medical Thawing System Market would witness market growth of 10% CAGR during the forecast period (2020-2026). Modern thawing systems permit fast thawing while keeping tissue quality intact. Moreover, characteristics like space-saving design, visual heater indicator, LED digital temperature display, and audiovisual high-temperature...
The Latin America, Middle East and Africa Medical Thawing System Market would witness market growth of 11.5% CAGR during the forecast period (2020-2026). The increasing number of surgeries and growing rates of hemorrhage-related conditions in these surgeries are boosting the growth of the medical thawing system. The demand for thawed...
United Arab Emirates
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.